As shown in Figure 2(a), TRAIL or periplocin alone had little effect on the viability of HCC cells, but the combination of these two drugs showed cytotoxicity to TRAIL-resistant HCC cells. This evidence concerns the gene TNFSF10 and hepatocellular carcinoma.